Your session is about to expire
← Back to Search
LIFT Procedure vs. Anal Fistula Plug for Anal Fistulas (LIFT vs PLUG Trial)
LIFT vs PLUG Trial Summary
This trial is comparing two common treatments for anal fistulae to see which is more effective.
LIFT vs PLUG Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowLIFT vs PLUG Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.LIFT vs PLUG Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I can understand and agree to the study's terms, or I have someone who can legally do this for me.I have no health issues that would prevent me from having surgery.I have a confirmed diagnosis of a trans-sphincteric fistula of cryptoglandular origin.I have a horseshoe fistula.I have not had immunosuppression therapy in the last 6 months.I have a non-healing wound near a surgical diversion.I have or might have Crohn's disease or ulcerative colitis.I have a connection between my rectum and vagina.I am 18 years old or older.
- Group 1: LIFT
- Group 2: Plug
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Are there opportunities for new enrollees in this clinical trial?
"As indicated on clinicaltrials.gov, this particular trial is no longer welcoming applicants despite being initially posted on March 1st 2009 and recently updated the 28th of May in the same year. Nonetheless, there are 110 other trials actively recruiting participants at present."
At how many sites can this clinical experiment be conducted?
"This trial is presently being facilitated at 4 distinct sites. Patients in Philadelphia, Minneapolis and Ottawa have convenient access to the research, along with those located near 4 other cities. It would be most prudent for participants to select a site closest to them so as not to overextend themselves during travel."
Who else is applying?
What state do they live in?
What site did they apply to?
What portion of applicants met pre-screening criteria?
How many prior treatments have patients received?
Why did patients apply to this trial?
Share this study with friends
Copy Link
Messenger